REFERENCE
1. Boersma LVA, Schmidt B, Betts TR, et al. Implant success and safety
of left atrial appendage closure with the WATCHMAN device:
peri-procedural outcomes from the EWOLUTION registry. Eur Heart
J . 2016;37(31):2465-2474.
2. Holmes DR, Doshi SK, Kar S, et al. Left Atrial Appendage Closure as
an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation:
A Patient-Level Meta-Analysis. J Am Coll Cardiol .
2015;65(24):2614-2623.
3. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the
management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J . 2016;37(38):2893-2962.
4. Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes
for predicting hemorrhage: Results from the National Registry of Atrial
Fibrillation (NRAF). Am Heart J . 2006;151(3):713-719.
5. Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk
stratification schemes for predicting stroke and thromboembolism in
patients with atrial fibrillation: Nationwide cohort study. Bmj .
2011;342(7792):320.
6. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score
(HAS-BLED) to assess 1-year risk of major bleeding in patients with
atrial fibrillation: The euro heart survey. Chest .
2010;138(5):1093-1100.
7. Landmesser U, Holmes DR. Left atrial appendage closure: A
percutaneous transcatheter approach for stroke prevention in atrial
fibrillation. Eur Heart J . 2012;33(6):698-704.
8. Alwi M, Leong MC. Catheter-Based Interventions on Intracardiac
Shunts .; 2014. 1127-1151p
9. Della Rocca DG, Horton RP, Di Biase L, et al. First Experience of
Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial
Appendage Closure. JACC Cardiovasc Interv . 2020;13(3):306-319.
10. Pillai AM, Kanmanthareddy A, Earnest M, et al. Initial experience
with post Lariat left atrial appendage leak closure with Amplatzer
septal occluder device and repeat Lariat application. Hear
Rhythm . 2014;11(11):1877-1883.
11. Ewert P, Berger F, Nagdyman N, et al. Masked left ventricular
restriction in elderly patients with atrial septal defects: A
contraindication for closure? Catheter Cardiovasc Interv .
2001;52(2):177-180.
12. King RL, Cleveland FM. Interauricular septal defect with mitral
stenosis; the Lutembacher syndrome. Bull Mason Clin .
1949;3(1):13-20.
13. Gutierrez C, Blanchard DG. Diastolic heart failure: Challenges of
diagnosis and treatment. Am Fam Physician . 2004;69(11):2609-2616.
14. Abdelkarim A, Levi DS, Tran B, Ghobrial J, Aboulhosn J. Fenestrated
Transcatheter ASD Closure in Adults with Diastolic Dysfunction and/or
Pulmonary Hypertension: Case Series and Review of the Literature.Congenit Heart Dis . 2016;11(6):663-671.
15. Schneider HE, Jux C, Kriebel T, Paul T. Fate of a modified
fenestration of atrial septal occluder device after transcatheter
closure of atrial septal defects in elderly patients. J Interv
Cardiol . 2011;24(5):485-490.
16. Akagi T. Current concept of transcatheter closure of atrial septal
defect in adults. J Cardiol . 2015;65(1):17-25.
17. Kuwata S, Vierecke J, Gloekler S, Maisano F, Meier B, Nietlispach F.
Left atrial appendage closure for “primary primary” prevention during
percutaneous closure of septal defects in patients with large atria but
no atrial fibrillation. Cardiol J . 2018;25(2):179-187.
18. Asmarats L, Cruz-González I, Nombela-Franco L, et al. Recurrence of
Device-Related Thrombus after Percutaneous Left Atrial Appendage
Closure. Circulation . 2019;140(17):1441-1443.
19. Dukkipati SR, Kar S, Holmes DR, et al. Device-related thrombus after
left atrial appendage closure: Incidence, predictors, and outcomes.Circulation . 2018;138(9):874-885.